Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
12/1998
12/23/1998CA2293614A1 Adjuvant compositions for vaccines
12/23/1998CA2293299A1 Compact epstein-barr virus replicons
12/23/1998CA2292912A1 Therapeutic composition and method of treatment
12/22/1998US5852199 Method for making carbamazephine derivative
12/22/1998US5852186 Reactive neutralizing human anti-GP120 recombinant antibody, DNA coding the same and use thereof
12/22/1998US5852183 Dog-mouse heterohybridoma and gene fragment coding for constant region of canine immunoglobulins
12/22/1998US5852176 Antibodies to receptors for human interleukin-12
12/22/1998US5852174 Antibodies to liver derived receptors for advanced glycosylation endproducts and uses therefor
12/22/1998US5852170 ICAM-4 materials and methods
12/22/1998US5852009 Compositions, including pharmaceutical compositions, for inhibiting the advanced glycosylation of proteins, and therapeutic methods based thereon
12/22/1998US5851999 FLK-1 is a receptor for vascular endothelial growth factor
12/22/1998US5851996 Materials and methods for treatment of plaquing diseases
12/22/1998US5851987 Human tumor-associated Kazal inhibitor-like polypeptides and encoding polynucleotides
12/22/1998US5851828 Targeted cytolysis of HIV-infected cells by chimeric CD4 receptor-bearing cells
12/22/1998US5851827 DNA encoding clostridium perfringens alpha-toxin peptides
12/22/1998US5851823 Hepatitis B vaccine
12/22/1998US5851813 Primate lentivirus antigenic compositions
12/22/1998US5851809 Tryptophanyl tRNA Synthetase polynucleotides of Streptococcus
12/22/1998US5851804 Chimeric kanamycin resistance gene
12/22/1998US5851801 Method of preparing polypeptide binding compositions derived from immunoglobulin variable regions
12/22/1998US5851798 Nucleic acid encoding human GPR14 receptor
12/22/1998US5851794 Collagen binding protein as well as its preparation
12/22/1998US5851793 Recombinant DNA encoding receptor protein for human B-cell stimulatory factor-2
12/22/1998US5851787 Nucleic acid encoding amyloid precursor-like protein and uses thereof
12/22/1998US5851786 Product and process to regulate actin polymerization
12/22/1998US5851779 Method for measuring carbamazepine in human serum
12/22/1998US5851774 Human MLF3 protein
12/22/1998US5851756 Method for in vitro proliferation of dendritic cell precursors and their use to produce immunogens
12/22/1998US5851535 Mimotopic polypeptides of Toxoplasma gondii and applications
12/22/1998US5851533 Vaccine based on membrane bound proteins and process for making them
12/22/1998US5851529 Recombinant retroviruses
12/22/1998US5851526 Methods of treating colon cancer utilizing tumor-specific antibodies
12/22/1998US5851523 Isolated, peptides derived from MAGE tumor rejection antigen precursors which complex with HLA-A2 molecules and uses thereof
12/22/1998US5851519 Live vaccines
12/22/1998CA2071955C Reduced-protein subunit vaccine for swine dysentery
12/20/1998CA2676074A1 Chromatographic method for high yield purification and viral inactivation of antibodies
12/20/1998CA2235445A1 Clostridium perfringens vaccine
12/20/1998CA2235444A1 Novel compounds
12/20/1998CA2235442A1 Response regulator
12/20/1998CA2235441A1 Novel compounds
12/20/1998CA2235437A1 Novel compounds
12/20/1998CA2235435A1 Novel compounds
12/20/1998CA2235433A1 Novel compounds
12/20/1998CA2235422A1 Novel compounds
12/18/1998CA2239605A1 Novel g-protein coupled receptor (h7tba62)
12/17/1998WO1998056951A1 Reagents and methods useful for detecting diseases of the lung
12/17/1998WO1998056933A1 Polypeptide presentation system
12/17/1998WO1998056929A1 Dna sequences, molecules, vectors and vaccines for feline calicivirus disease and methods for producing and using same
12/17/1998WO1998056919A2 Methods and reagents for vaccination which generate a cd8 t cell immune response
12/17/1998WO1998056917A1 Methods and compositions for the expression of a bone and prostate derived growth factor
12/17/1998WO1998056913A1 Smad6 and uses thereof
12/17/1998WO1998056911A1 Human phosphatidylinositol transfer protein gamma
12/17/1998WO1998056901A2 Live attenuated vaccines
12/17/1998WO1998056896A1 Method of attenuating viruses
12/17/1998WO1998056894A1 Electrospraying apparatus and method for introducing material into cells
12/17/1998WO1998056816A1 VACCINE COMPOSITIONS COMPRISING THE HELICOBACTER PYLORI FlgE POLYPEPTIDE
12/17/1998WO1998056815A1 VACCINE COMPOSITIONS COMPRISING THE HELICOBACTER PYLORI Pfr POLYPEPTIDE
12/17/1998WO1998056420A1 Ganglioside immunostimulating complexes and uses thereof
12/17/1998WO1998056419A1 Methods of delaying development of hmfg-associated tumors using anti-idiotype antibody 11d10
12/17/1998WO1998056418A1 Stabilized antibody formulation
12/17/1998WO1998056417A1 Composition and method to prevent graft rejection and other counter-adaptive t lymphocyte mediated immune responses
12/17/1998WO1998056416A1 Immunogenic compositions for induction of anti-tumor immunity
12/17/1998WO1998056415A1 Purified saponins as oral adjuvants
12/17/1998WO1998056414A1 Oil in water vaccine compositions
12/17/1998WO1998056413A1 Multivalent in ovo avian vaccine
12/17/1998WO1998056412A1 VACCINE COMPOSITIONS COMPRISING THE HELICOBACTER PYLORI 26kDa POLYPEPTIDE
12/17/1998WO1998056325A1 Drug delivery devices and methods for treatment of viral and microbial infections and wasting syndromes
12/17/1998WO1998039034A3 Use of preparations containing anti-cd44 antibodies in the treatment of certain tumours and the suppression of immune reactions
12/17/1998WO1998037093A3 Compounds for immunotherapy of prostate cancer and methods for their use
12/17/1998WO1998033919A3 Anti-alpha-v beta-3 recombinant humanized antibodies, nucleic acids encoding same and methods of use
12/17/1998WO1998030586A3 Diagnostics and therapy of epstein-barr virus in autoimmune disorders
12/17/1998CA2301196A1 Multivalent in ovo avian vaccine
12/17/1998CA2295176A1 Drug delivery devices and methods for treatment of viral and microbial infections and wasting syndromes
12/17/1998CA2294069A1 Methods of delaying development of hmfg-associated tumors using anti-idiotype antibody 11d10
12/17/1998CA2293444A1 Oil in water vaccine compositions
12/17/1998CA2293439A1 Ganglioside immunostimulating complexes and uses thereof
12/17/1998CA2293293A1 Vaccine compositions comprising the helicobacter pylori flge polypeptide
12/17/1998CA2293250A1 Human phosphatidylinositol transfer protein gamma
12/17/1998CA2292900A1 Live attenuated vaccines
12/17/1998CA2292788A1 Reagents and methods useful for detecting diseases of the lung
12/17/1998CA2292339A1 Smad6 and uses thereof
12/17/1998CA2291338A1 Composition and method to prevent graft rejection and other counter-adaptive t lymphocyte mediated immune responses
12/17/1998CA2263993A1 Method of attenuating viruses
12/16/1998EP0884388A1 Transgenic plants containing recombinant mistletoe lectin (rML)
12/16/1998EP0884382A2 Processes for preparation of marek's disease virus using continuous mammalian cell lines
12/16/1998EP0884329A1 Anti-idiotypic antibody which induces an immune response against a glycosphingolipid and use thereof
12/16/1998EP0884056A1 Vaccines containing a saponin and a sterol
12/16/1998EP0883688A1 Adapter molecules for targeting viral particles to cells
12/16/1998EP0883625A1 Novel platelet activation protein
12/16/1998EP0652962B1 Expression of recombinant fusion proteins in attenuated bacteria
12/16/1998EP0610447B1 CDw52 - SPECIFIC ANTIBODY FOR TREATMENT OF T-CELL MEDIATED INFLAMMATION OF THE JOINTS
12/16/1998EP0575553B1 Recombinant hybrid porin epitopes
12/16/1998CN1202201A Polyvalent anti-dengue vaccine
12/16/1998CN1201694A Process for preparation of immune globulin for introvenous injection by dual inactivation of virus without protectives
12/16/1998CN1201693A Chick lecithal immune globulin products against rolavirus and its use and its testing method of activity
12/16/1998CN1201692A Vaccine
12/16/1998CA2206774A1 "prionins", highly specific markers for noninvasive presymptomatic defection of tse diseases, and targets for therapeutic reagents to prevent and control tse diseases in animals and humans
12/15/1998US5849901 DNA fragments of mycobacteria, amplification primers hybridization probes, reagents and method for the detection of mycobacteria
12/15/1998US5849876 Hybridomas producing monoclonal antibodies to new mucin epitopes
12/15/1998US5849871 α-melanocyte stimulating hormone receptor
1 ... 1552 1553 1554 1555 1556 1557 1558 1559 1560 1561 1562 1563 1564 1565 1566 1567 1568 1569 1570 1571 1572 ... 1823